These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 11836356)

  • 21. Novel SOST gene mutation in a sclerosteosis patient and her parents.
    Bhadada SK; Rastogi A; Steenackers E; Boudin E; Arya A; Dhiman V; Bhansali A; Van Hul W
    Bone; 2013 Feb; 52(2):707-10. PubMed ID: 23079137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Loss-of-Sclerostin Function Mutation in a First Egyptian Family with Sclerosteosis.
    Fayez A; Aglan M; Esmaiel N; El Zanaty T; Abdel Kader M; El Ruby M
    Biomed Res Int; 2015; 2015():517815. PubMed ID: 25984533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted deletion of Sost distal enhancer increases bone formation and bone mass.
    Collette NM; Genetos DC; Economides AN; Xie L; Shahnazari M; Yao W; Lane NE; Harland RM; Loots GG
    Proc Natl Acad Sci U S A; 2012 Aug; 109(35):14092-7. PubMed ID: 22886088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Van Buchem disease: clinical, biochemical, and densitometric features of patients and disease carriers.
    van Lierop AH; Hamdy NA; van Egmond ME; Bakker E; Dikkers FG; Papapoulos SE
    J Bone Miner Res; 2013 Apr; 28(4):848-54. PubMed ID: 23074140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational and functional characterization of four SNPs in the SOST locus associated with osteoporosis.
    Ye W; Wang Y; Mei B; Hou S; Liu X; Wu G; Qin L; Zhao K; Huang Q
    Bone; 2018 Mar; 108():132-144. PubMed ID: 29307778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function.
    Piters E; Culha C; Moester M; Van Bezooijen R; Adriaensen D; Mueller T; Weidauer S; Jennes K; de Freitas F; Löwik C; Timmermans JP; Van Hul W; Papapoulos S
    Hum Mutat; 2010 Jul; 31(7):E1526-43. PubMed ID: 20583295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression and regulation of the SOST gene].
    Qin LJ; Ding DX; Cui LL; Huang QY
    Yi Chuan; 2013 Aug; 35(8):939-47. PubMed ID: 23956082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with Van Buchem disease, an osteosclerotic genetic disease, have elevated bone formation markers, higher bone density, and greater derived polar moment of inertia than normal.
    Wergedal JE; Veskovic K; Hellan M; Nyght C; Balemans W; Libanati C; Vanhoenacker FM; Tan J; Baylink DJ; Van Hul W
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5778-83. PubMed ID: 14671168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A rare cause of facial nerve palsy in children: hyperostosis corticalis generalisata (Van Buchem disease). Three new pediatric cases and a literature review.
    van Egmond ME; Dikkers FG; Boot AM; van Lierop AH; Papapoulos SE; Brouwer OF
    Eur J Paediatr Neurol; 2012 Nov; 16(6):740-3. PubMed ID: 22445802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SOST is a target gene for PTH in bone.
    Keller H; Kneissel M
    Bone; 2005 Aug; 37(2):148-58. PubMed ID: 15946907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Mutation in a Gene Causes Sclerosteosis in a Family of Mediterranean Origin.
    Ekhzaimy AA; Alyusuf EY; Alswailem M; Alzahrani AS
    Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208525
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular Basis for Craniofacial Phenotypes Caused by Sclerostin Deletion.
    Chen J; Yuan X; Pilawski I; Liu X; Delgado-Calle J; Bellido T; Turkkahraman H; Helms JA
    J Dent Res; 2021 Mar; 100(3):310-317. PubMed ID: 33078679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sclerostin deficiency in humans.
    van Lierop AH; Appelman-Dijkstra NM; Papapoulos SE
    Bone; 2017 Mar; 96():51-62. PubMed ID: 27742500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The sclerostin story: from human genetics to the development of novel anabolic treatment for osteoporosis.
    Yavropoulou MP; Xygonakis C; Lolou M; Karadimou F; Yovos JG
    Hormones (Athens); 2014; 13(4):323-37. PubMed ID: 25555179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sclerostin: current knowledge and future perspectives.
    Moester MJ; Papapoulos SE; Löwik CW; van Bezooijen RL
    Calcif Tissue Int; 2010 Aug; 87(2):99-107. PubMed ID: 20473488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of the gene for hyperostosis cranialis interna to chromosome 8p21 with analysis of three candidate genes.
    Borra VM; Waterval JJ; Stokroos RJ; Manni JJ; Van Hul W
    Calcif Tissue Int; 2013 Jul; 93(1):93-100. PubMed ID: 23640157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Van Buchem disease: surgical treatment of the mandible.
    Schendel SA
    Ann Plast Surg; 1988 May; 20(5):462-7. PubMed ID: 3377422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dyggve-Melchior-Clausen syndrome and Smith-McCort dysplasia: clinical and molecular findings in three families supporting genetic heterogeneity in Smith-McCort dysplasia.
    Neumann LM; El Ghouzzi V; Paupe V; Weber HP; Fastnacht E; Leenen A; Lyding S; Klusmann A; Mayatepek E; Pelz J; Cormier-Daire V
    Am J Med Genet A; 2006 Mar; 140(5):421-6. PubMed ID: 16470731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Syndactyly/brachyphalangy and nail dysplasias as marker lesions for sclerosteosis.
    Itin PH; Keserü B; Hauser V
    Dermatology; 2001; 202(3):259-60. PubMed ID: 11385236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling.
    ten Dijke P; Krause C; de Gorter DJ; Löwik CW; van Bezooijen RL
    J Bone Joint Surg Am; 2008 Feb; 90 Suppl 1():31-5. PubMed ID: 18292354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.